Allergan Showcases Leadership in Neurosciences with 25 Presentations at the American Academy of Neurology Annual Meeting in Los Angeles

Author's Avatar
Apr 20, 2018
Article's Main Image

-- Phase 3 Oral CGRP Results for Ubrogepant Accepted as Late Breaker Emerging Science Presentation --

PR Newswire